You can find a range of patient information handouts, including dialysis options, vascular access and GN information in the For Patients section of the website.
New Renal Program and Facility Development
Pharmacy and Formulary
- Hemodialysis Clinical Decision Support Tools
- Dialyzability of Drugs in Intermittent Hemodialysis
- Intradialytic Parenteral Nutrition (IDPN) Guidelines
- Heparin Adjustment Protocol (under revision)
- Hemodialysis: Circle Protocol for Temporary Interruption of Dialysis (under revision)
- Intradialytic Hypotension Protocol (under revision)
- Renal Precaution Orders
- The Clinical Practice Guidelines for Physicians have been developed by the Guidelines and Protocols Advisory Committee on behalf of the Medical Services Commission. The guidelines are intended to give an understanding of a clinical problem and outline one or more preferred approaches to the investigation and management of the problem.
- 1a - Microbial Testing of Dialysate
- 1b - Microbial Testing of Dialysis Water
- 2a - Endotoxin Testing of Dialysate
- 2b - Endotoxin Testing of Dialysis Water
- 3 - Chemical Analyses of Dialysis Water
- 4 - Daily Chlorine Testing of Dialysis Water
- 6 - Dialysis Water Equipment Monitoring
Drug removal during hemodialysis affects drug effectiveness, the administration timing around the dialysis schedule, and the needs for supplemental dosing. This website contains dialyzability data from a literature review of pharmacokinetic studies in intermittent hemodialysis, pharmacokinetic parameters of the drugs, along with drug dosing recommendations in intermittent hemodialysis.
- Calcium Management Guideline for Patients Receiving Extended Duration Hemodialysis
- Phosphate Management Guideline for Patients Receiving Extended Duration Hemodialysis
- Citrasate® Dialysate for Independent Extended Duration Hemodialysis Treatments
- Iron Repletion Algorithm
- System Redesign Risk Assessment Report
- Gambro Order Site
- Gambro Online Ordering Information
- Emergency Disconnect Procedures (Catheter or Fistula/Graft) for the AK 95S model:
- Emergency Disconnect Procedures (Catheter or Fistula/Graft) for the AK 96 model:
- BCPRA Approach to Managing AROs in BC Hemodialysis Units
- PICNet Antibiotic Resistant Organisms Prevention and Control Guidelines (Refer to section 6.15-6.23, pages 44-49)
- Guideline: Best Practices for Kidney Care Clinics
- Common Prescribing Questions for Patients with Chronic Kidney Disease not on Dialysis
- Medication Reconciliation
- Ordering, Reviewing & Follow-Up of Lab Work
- Standing Lab Work Orders
The following policies and procedures were developed for use within the BC Children’s Hospital Renal Program. These will benefit and standardize the care effectively to most pediatric patients in whom they are applied. It remains the treating physician’s responsibility to consider any unique issues that might be pertinent to the current scenario and to make adjustments to the application of the guidelines to best treat the individual patient.
- Peritonitis Management
- Antibiotic Treatment of Peritonitis (For Parents and Allied Health Professionals)
- Empiric Management of Peritonitis (On-Call Handbook)
- Pediatric Dialysis: Antibiotic Stability Chart
- Assisting with the Bedside (Percutaneous) Insertion of Chronic Peritoneal Dialysis Catheters
- Assisting with the Bedside (Percutaneous) Removal of Chronic Peritoneal Dialysis Catheters
- Bedside (Percutaneous) Insertion/Removal of Chronic Peritoneal Dialysis Catheters
- Warming Peritoneal Dialysis Solutions
- Provincial Renal Program Guidelines provide a framework for health authorities to follow in the development and management of programs. These guidelines – the first of their kind in Canada – were developed by BCPRA and the renal care community, and are formally endorsed by the BC Ministry of Health. The goal of the guidelines is to support equitable distribution of high quality renal care to patients across BC.
- The Clinical Practice Guideline for Physicians have been developed by the Guidelines and Protocols Advisory Committee on behalf of the Medical Services Commission. The Guidelines are intended to give an understanding of a clinical problem and outline one or more preferred approaches to the investigation and management of the problem.